← Open Payments lookup

RYAN SPERL: Open Payments

NPI 1912410408 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,228 in 116 payments from 45 companies in 2025. Trend: 2023 $3,900 · 2024 $3,211 · 2025 $4,228

Food & beverage: $4,228
CompanyPaymentsAmount
Janssen Biotech, Inc.12$448
AstraZeneca Pharmaceuticals LP9$371
Janssen Scientific Affairs, LLC2$201
Stemline Therapeutics Inc.4$178
Incyte Corporation4$177
GlaxoSmithKline, LLC.5$169
Genmab U.S., Inc.3$159
SERVIER PHARMACEUTICALS LLC2$159
Pharmacosmos Therapeutics Inc.5$159
Exelixis Inc.3$145

Products named: RYBREVANT, DARZALEX, Orserdu, MONOFERRIC, MONJUVI, JEMPERLI, CABOMETYX, OPDIVO.

Industry payments across TX — which companies pay providers there.